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ABSTRACT
Objective: To explore the associations between general practitioners (GPs) characteristics such
as gender, specialist status, country of birth and country of graduation and the quality of care
for patients with type 2 diabetes (T2DM).
Design: Cross-sectional survey.
Setting and subjects: The 277 GPs provided care for 10082 patients with T2DM in Norway in
2014. The GPs characteristics were self-reported: 55% were male, 68% were specialists in General
Practice, 82% born in Norway and 87% had graduated in Western Europe. Of patients, 81% were
born in Norway and 8% in South Asia. Data regarding diabetes care were obtained from elec-
tronic medical records and manually verified.
Main outcome measures: Performance of recommended screening procedures, prescribed
medication and level of HbA1c, blood pressure and LDL-cholesterol stratified according to GPs
characteristics, adjusted for patient and GP characteristics.
Result: Female GPs, specialists, GPs born in Norway and GPs who graduated in Western Europe
performed recommended procedures more frequently than their counterparts. Specialists
achieved lower mean HbA1c (7.14% vs. 7.25%, p< 0.01), a larger proportion of their patients
achieved good glycaemic control (HbA1c¼ 6.0%–7.0%) (49.1% vs. 44.4%, p¼ 0.018) and lower
mean systolic blood pressure (133.0mmHg vs. 134.7mmHg, p< 0.01) compared with non-spe-
cialists. GPs who graduated in Western Europe achieved lower diastolic blood pressure than their
counterparts (76.6mmHg vs. 77.8mmHg, p< 0.01).
Conclusion: Several quality indicators for type 2 diabetes care were better if the GPs were
specialists in General Practice.
KEY POINTS
 Research on associations between General Practitioners (GPs) characteristics and quality of
care for patients with type 2 diabetes is limited.
 Specialists in General Practice performed recommended procedures more frequently, achieved
better HbA1c and blood pressure levels than non-specialists.
 GPs who graduated in Western Europe performed screening procedures more frequently and
achieved lower diastolic blood pressure compared with their counterparts.
 There were few significant differences in the quality of care between GP groups according to
their gender and country of birth.
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Introduction
Type 2 diabetes (T2DM) increases the risk of coronary
heart disease (CHD) and often coexists with hyperten-
sion and dyslipidemia which add additional risk for
cardiovascular complications and mortality [1,2]. When
multiple risk factors such as life style factors, hypergly-
caemia, hypertension and dyslipidemia are addressed
simultaneously, vascular complications can be
reduced [3,4].
The quality of T2DM care is affected by healthcare
system factors such as health care organization, clinical
guidelines, financial incentives [5–7], but also by health
provider characteristics such as age, gender, speciality
[7,8] and patient characteristics such as age, gender,
socioeconomic position and ethnicity [7,9–12].
The Norwegian government offers state-funded
health care service to all citizens. Norwegian guidelines
for the diagnosis, treatment and follow up of diabetes
patients have been published since the 1980’s with
the aim of improving the quality of care. General prac-
titioners (GPs) with or without specialist training and
approval as specialist in General Practice provide care
for most patients with T2DM in majority of European
counties including Norway [13,14]. Few studies have
explored whether the quality of diabetes care is associ-
ated with the characteristics of GPs. In studies related
to gender, female physicians, achieved better [15] or
similar treatment targets for HbA1c, systolic blood
pressure (SBP) and LDL-cholesterol compared with
male physicians [16]. In studies comparing GP care
with specialist care, GPs performed processes of care
less often [17], but achieved lower mean HbA1c com-
pared with specialists in endocrinology [18]. It is not
known whether factors such as specialist training, for-
mal specialist approval, GP’s country of birth or GP’s
country of graduation are associated with the quality
of diabetes care.
In Norway, approximately 57% of all GPs have a for-
mal specialist approval achieved after completing the
Specialist Education for General Practice [19]. Specialist
approval requires re-certification every fifth year [20].
About 20% of GPs are born outside Norway [21].
Regardless of country of birth, there is an increasing
proportion of GPs who have graduated abroad [19].
The qualifications of all GPs practicing in Norway are
approved by the regulating authorities [20]. GPs who
graduated in countries in the European Union (EU) or
European economic areas (EEA) have to complete an
internship, while GPs graduated outside EU/EEA have
to meet additional requirements before they can apply
for Norwegian authorization.
The primary aim of this study was to explore associ-
ations between the GP’s gender, specialist status,
country of birth and region of graduation and the
quality of care for patients with T2DM as measured by
the performance of processes of care, prescribed medi-
cation and intermediate outcomes (level of HbA1c,
blood pressure and LDL-cholesterol). The secondary
aim was to evaluate the associations between GPs
characteristics and the intermediate outcomes accord-
ing to patient gender and ethnicity.
Material and methods
Design, setting and participants
The present study is part of a cross-sectional survey,
the ROSA4 study, assessing the quality of diabetes
care in general practice in Norway in 2014. We
selected 16 municipalities in five counties (Oslo,
Akershus, Rogaland, Hordaland and Nordland). In total,
106 practices with 367 GPs were invited.
Data collection and variables
Data regarding the participating GPs and the care of
their patients were collected from January 2015 to
April 2016 by research nurses.
A questionnaire was used to gather self-reported
GP characteristics (age, gender, specialist status, coun-
try of birth, country of graduation, year of Norwegian
authorization and number of years working as GP
in Norway).
Based on self-reported information GPs were
grouped into 1) male or female, 2) specialists or non-
specialists, 3) born in Norway or other countries, 4)
graduated in Western Europe or other (Eastern Europe,
Asia, Africa, America). The number of patients on the
GPs lists was obtained from the Norwegian Health
Economics Administration at the time of data collec-
tion. Based on characteristic of the area in which the
practices were located, the practices were grouped as
either urban or rural practices.
A software program was used to identify all
patients (18 years) with a diabetes diagnosis
between 2012–2014 and capture pre-defined data
including results of the blood tests, urine tests and
prescriptions from electronic medical records (EMRs).
The research nurse examined the EMRs to verify the
diabetes diagnosis, electronically registered data and
to collect relevant data not suitable for electronic cap-
ture such as complications. Variables used in the pre-
sent study included: patient characteristics (age,
gender, diabetes duration); processes of care
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(documentation of HbA1c, blood pressure, LDL-choles-
terol, creatinine/estimated glomerulofiltration rate
(eGFR), albuminuria, body height, body weight, eye
examination, foot examination, smoking habits, referral
to ophthalmologists, endocrinologists and internists);
pharmacological therapy (prescriptions of glucose low-
ering-, antihypertensive-, and lipid lowering- and
antithrombotic agents); intermediate outcomes
(HbA1c, blood pressure, LDL-cholesterol); macrovascu-
lar complications (CHD (angina, myocardial infarction,
percutaneous coronary intervention/coronary artery
bypass surgery), stroke (excluding transient ischemic
attacks), percutaneous transluminal angioplasty/arterial
surgery). For the majority of variables, most recently
recorded value from period October 1st 2013 to
December 31st 2014 was used, for smoking habits
(January 1st 2010 to December 31st 2014), eye examin-
ation and referral to ophthalmologists (July 1st 2012 to
December 31st 2014) and referral to endocrinologists
or internists (January 1st 2013 to December 31st 2014).
Treatment targets were based on key recommenda-
tions in the Norwegian 2009-guildelines: HbA1c 
7.0%, BP  135/80mmHg, LDL-cholesterol 
1.8mmol/L or 2.5mmol/L for patients with or without
known macrovascular complications respectively [22].
All Norwegian citizens are given a unique personal
identification number (ID-number) at birth. Based on
this number, we obtained information about country
of birth and educational level from Statistics Norway.
The patient’s ethnicity was based on country of birth
and is categorized as 1) Norwegians (born in Norway),
2) South Asians (born in Pakistan, Sri Lanka, India and
Bangladesh) and 3) Other (born in other countries).
The patient’s education was grouped into 1) preprimary
and primary education 2) secondary education and
3) tertiary education, in accordance with the
International Standard Classification of Education [23].
Statistical analyses
We performed analyses stratified by GPs characteristics
and compared the processes of care, pharmacological
therapy and intermediate outcomes between these GP
groups. Descriptive statistics in the form of frequencies
(proportions) and medians (percentiles) were used to
describe the characteristics of the GPs and their
patients. The independent-samples T-tests were used
to compare mean differences of numerical variables
between different GP groups while associations
between GP and patient factors with GP groups were
established from the Chi-square tests.
We fitted two-level and three-level regression mod-
els to account for the dependence of patients’ data
within GPs, who were in turn clustered/nested within
GP practices. To that end, binary multilevel regression
models were fitted to the data on proportions while
linear multilevel regression models were fitted to inter-
mediate continuous outcomes. All models were
adjusted for patient’s level characteristics (age, gender,
ethnicity and education) while further adjustments
using the GP-level characteristics (age, gender, special-
ist status, country of birth and region of graduation)
were done in the three-level models. As there was
strong correlation between GPs age and years as GP
in Norway, we included only GPs age in our adjust-
ments. As we tested a number of hypotheses, we used
the Benjamin Hochberg procedure to control for mul-
tiple testing and the significance level was set at
<0.05. The analyses were performed with SPSS
Statistics 24 and StataSE 14.
Results
Of the invited practices, 77 (73%) with 282 GPs (77%)
participated. We received completed questionnaires
from 277 (98%) GPs. In total, 55% of GPs were male,
68% were specialists, 82% were born in Norway and
87% graduated in a Western European country. Male
GPs, specialists and GPs who had graduated in
Western Europe were more likely to be older and to
have had more years practising as a GP in Norway
(Table 1).
Altogether, the GPs had 342 044 patients on their
lists. In total, 11 428 patients with a diabetes diagnosis
were identified. We excluded patients with other than
T2DM (n¼ 1180) and those who were registered with
the participating GPs but received care from another
doctor (n¼ 166), leaving 10082 patients with T2DM to
be included in the study. Of these, 81% were born in
Norway, 8% were born in South Asia and 11% born in
other countries. Interestingly, the ethnic composition
and educational level of patients on the GPs’ lists var-
ied significantly between the GP groups (Table 1).
Processes of care
The GPs measured HbA1c in 89%, BP in 88% and LDL-
cholesterol in 68% of T2DM patients. They performed
U-albumin and foot examination in only 32% and 30%
of patients, respectively. Significant differences in the
processes of care between the GP groups were
observed, data not shown. After adjustments for
patient characteristics, several differences persisted
(Table 2). Female GPs, specialists, GPs born in Norway
and GPs who graduated in Western Europe performed
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recommended procedures more frequently than their
counterparts.
Medication
Overall, GPs treated 32% of patients with lifestyle
modification (i.e. advice about diet and physical activ-
ity) alone and 68% with glucose lowering agents. GPs
prescribed antihypertensive- and lipid lowering-gents
to 65% and 54% of patients, respectively. Differences
in prescriptions of relevant medication were observed
between the GPs groups. GPs born outside Norway
and GPs who graduated outside Western Europe pre-
scribed glucose lowering more frequently and antihy-
pertensive agents less frequently than their
counterparts, data not shown. However, after adjust-
ments for patient characteristics and diabetes duration,
there were no differences in prescriptions of glucose
lowering, antihypertensive- and lipid lowering agents
by GP groups (Table 3).
Intermediate outcomes
Overall, the GPs achieved HbA1c 7.0% for 62% of
their T2DM patients, SBP  135mmHg for 50% and
DBP 80mmHg for 46% of patients, respectively. They
also achieved LDL-cholesterol  1.8mmol/L in 29% of
patients with macrovascular complications and LDL-
cholesterol  2.5mmol/L in 40% of patients without
macrovascular complications.
Several intermediate outcomes varied significantly
according to GP characteristics, data not shown. After
adjustments for patient characteristics, GPs age, coun-
ties and clustering within practices, significant differen-
ces in level of HbA1c and BP between GP groups were
observed (Table 4). Compared with non-specialists,
specialists achieved significantly lower mean HbA1c
and SBP for their patients. More patients cared for by
specialists achieved good glycaemic control
(HbA1c¼ 6.0 to 7.0%) than patients of non-specialists
(49.1 vs. 44.4%, p< 0.018) (Figure 1).
Discussion
To the best of our knowledge, our study is the first to
study the associations between several GP characteris-
tics and the quality of care delivered to patients with
T2DM in general practice. Interestingly patient charac-
teristics differed by GP groups. Female GPs, non-spe-
cialists, GPs born outside Norway and GPs who had
graduated outside Western Europe had a significantly
higher proportion of patients born in South Asia and
other countries.
The performance of most processes of care varied
between all GP groups even after adjusting for con-
founding factors related to patients and GPs. Female
GPs, specialists, GPs born in Norway and GPs who had
graduated in Western Europe performed recom-
mended procedures more frequently than their coun-
terparts. Prescription of relevant medication varied
little by GP groups. Several intermediate outcomes
Table 2. Performed processes of care for patients with type 2 diabetes according to the general practitioner’s characteristics
adjusted for patient characteristics.
General practitioner’s characteristics
Gender Specialist status Country of birth Region of graduation
Features recorded in EMRs
Male
n¼ 153
Female
n¼ 124
Specialist
n¼ 187
Non-specialist
n¼ 90
Norway
n¼ 210
Other
n¼ 46
Western Europe
n¼ 222
Other
n¼ 33
HBA1ca 89.0 90.0 90.2 87.0 89.8 87.7 90.0 85.3
Blood pressurea 87.4 89.1 89.3 84.7 89.0 84.7 88.7 84.7
S-LDL-cholesterola 66.3 70.7 68.3 66.8 67.1 70.3 67.7 67.3
S-Creatinine/S-eGFRa 82.3 85.6 84.3 81.3 83.9 82.2 83.9 80.6
U-Albumina 32.6 34.1 34.4 29.9 32.9 35.1 34.0 28.8
Body heightb 69.5 68.9 71.1 64.5 71.7 61.1 70.8 61.6
Body weighta 53.3 52.0 54.9 47.7 55.5 46.0 54.6 47.7
Eye examinationc 56.0 57.8 58.1 53.2 57.2 53.2 57.7 47.1
Foot examinationa 28.8 31.4 31.1 26.3 31.2 25.7 30.3 29.4
Smoking habitsb 80.5 78.0 80.4 77.4 81.0 72.7 80.4 72.6
Referral to ophthalmologistc 18.6 16.9 18.1 17.9 18.7 15.1 18.7 13.4
Referral to endocrinologistd 3.5 4.6 3.8 4.5 4.2. 2.9 4.1 2.7
Referral to other internistd 7.7 9.2 7.9 9.1 8.4 6.8 8.2 7.2
Data are % unless otherwise stated.
EMRs: Electronic medical records.
Data from a: Oct. 1st 2013 to Dec. 31st 2014 (15 months); b: Jan. 1st to 2010 Dec. 31.st 2014 c: Jul. 1st 2012 to Dec. 31st 2014 (30 months); d: Jan. 1st 2013
to Dec. 31st 2014 (24 months).p< 0.05.p< 0.01.p< 0.001. Multilevel binary logistic regression models with random effects at GP practice level were used to compare the differences in proportions
between the general practitioner groups after adjusting for patient age, gender, ethnicity, education level and counties.
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varied by GPs characteristics with specialists achieving
lower HbA1c and SBP levels, and a higher proportion
of their patients achieved good glycaemic control with
HbA1c between 6.0% and 7.0%, though the effect
sizes were small. Interestingly, female GPs achieved
better glycaemic control for their South Asian patients
than male GPs.
Strengths and weaknesses
This study has several strengths as it is a large nation-
wide study with a high participation rates for GPs and
all their patients were included, indicating little selec-
tion bias. The invited practices were of varied size,
mostly located in urban, but some also in rural areas.
The participating GPs were considered to be fairly rep-
resentative for the GP population in Norway despite
some differences. The proportion GPs with a specialist
approval was higher than among all GPs in Norway
(67.5% vs. 57.1%) and slightly more had graduated
from Western Europe (88.2% vs. 82.1%) [21]. The mean
age for the participating female GPs was similar to
mean age for all female GPs in Norway (46 years vs.
45 years) while male GPs were somewhat older than
all male GPs (mean age 55 years vs. 50 years).
However, the mean number of patients on GPs’ lists
was close to the mean for all GPs in Norway (GPs in
the study 1213 vs. all GPs in Norway 1132) [24].
Another important strength is that we received per-
mission to link patient data with national registry data
to obtain information about country of birth and edu-
cation. Manual verification of diabetes diagnosis and
the electronically extracted data by experienced nurses
contributes to the internal validity of this study.
However, the study has some limitations. We do
not know why 23% of the invited practices declined to
participate in the study. Non-specialists were a diverse
group, consisting of GPs who were currently under-
going the Specialist Education for General Practice and
those who had practiced for a short or long time as a
GP without participating in or completing the
Specialist Education for General Practice. There were
few GPs who had graduated outside Western Europe
among the participating GPs, limiting the power to
detect group differences. We also lack information
about how the GPs approached lifestyle management
and data about the patients diabetes self-care includ-
ing compliance to prescribed medication.
Table 3. Glucose lowering-, antihypertensive- and lipid lowering therapy for patients with type 2 diabetes according to the gen-
eral practitioner’s characteristics adjusted for patient characteristics.
General practitioner’s characteristics
Gender Specialist status Country of birth Region of graduation
Medication (%)
Male
n¼ 153
Female
n¼ 124
Specialist
n¼ 187
Non-specialist
n¼ 90
Norway
n¼ 210
Other
n¼ 46
Western Europe
n¼ 222
Other
n¼ 33
Glucose loweringa
Lifestyle modification 31.2 32.9 32.4 30.3 32.6 26.4 31.5 30.8
All glucose lowering agents without insulin 52.5 52.2 52.0 53.6 51.8 57.9 52.8 54.0
Insulin only 5.8 5.2 5.5 5.6 5.3 6.7 5.4 6.6
Insulin combined with other glucose lowering agents 10.4 9.7 10.0 10.5 10.3 9.0 10.3 8.6
Metformin 57.9 57.1 57.6 57.5 57.3 60.9 58.1 57.6
Sulfonylurea 18.5 17.4 17.6 19.6 18.0 19.0 18.2 18.2
DPP4 inhibitors 14.0 14.2 13.7 15.3 13.2 17.6 13.3 19.2
GLP 1 agonists 3.0 3.2 3.1 3.0 3.2 3.2 3.2 3.0
SGLT-2 inhibitors 3.5 3.9 3.7 3.7 3.3 5.8 3.7 4.9
Number of glucose lowering agents including insulin
1 agent 35.6 35.1 35.5 35.1 35.2 39.0 35.9 35.9
2 agents 23.1 21.6 22.0 24.6 22.5 22.6 22.8 20.3
 3 glucose-lowering agents 9.8 10.4 10.0 10.1 9.7 12.0 9.7 13.1
Antihypertensive
Antihypertensive agents 65.8 65.5 62.7 66.8 66.1 66.3 66.4 63.8
ACE/AII inhibitors 51.3 53.6 51.1 52.6 52.5 52.5 52.7 51.1
Betablockers 30.7 30.2 28.2 31.4 30.8 30.9 30.9 29.7
Calcium channel blockers 25.8 25.4 25.2 25.8 25.6 26.1 25.8 24.3
Tiazides 26.0 27.3 25.6 26.9 27.0 25.7 26.9 25.5
Number of antihypertensives
1 agent 19.4 19.1 19.1 19.4 19.6 19.1 19.6 18.2
2 agents 20.5 19.9 18.5 21.0 20.1 21.3 20.2 20.9
3 agents 16.0 16.6 15.8 16.4 16.2 17.0 16.4 16
 4 antihypertensive agents 9.9 9.8 9.3 10.1 10.2 9.0 10.1 8.7
Lipid lowering 53.8 55.5 52.6 55.2 54.7 54.5 54.8 53.8
p< 0.05.p< 0.01.p< 0.001. Multilevel binary logistic regression models with random effects at GP practice level were used to compare the differences in proportions
between the general practitioner groups after adjusting for age, gender, ethnicity, education level, counties and
adiabetes duration.
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Findings in relation to other studies
Educating GPs in endocrinology and diabetes care
through specialist-outreach has shown benefits on
improving GPs knowlegde [25]. Financial incentives
for performance of diabetes care in the United
Kingdom has been shown to improve both processes
of care and intermediate outcomes for patients with
diabetes [5]. Specialist approval itself is in Norway
accompanied by a financial incentive which is not
related to the performance of processes of care or
achievements of treatment targets. The Specialist
Education for General Practice is an appropriate way
for doctors who have limited experience of practic-
ing as a GP to improve their knowledge about treat-
ment of several diseases including diabetes. To the
best of our knowledge, re-certification every fifth
year for all specialists in General Practice in Norway
is unique and promotes continuous education of GPs
holding a specialist approval. Both ways of updating
professional knowledge may enhance the GP’s com-
petency and improve their clinical practice. This strat-
egy may explain the observed differences between
specialists compared with non-specialists in our
study. However, the differences in intermediate out-
comes between specialists and non-specialists were
in clinical terms small. A possible explanation is that
the difference between the two groups has been
reduced as a large proportion of current non-special-
ists intend to become specialists and might be cur-
rently undergoing the Specialist Education for
General practice.
Compared with male GPs, female GPs provided bet-
ter performance of the processes of care but achieved
similar intermediate outcomes for all patients, except
lower HbA1c for South Asians. The results are consist-
ent with that reported by Kim and colleagues [16].
They found that female GPs performed slightly more
lipid and HbA1c measurements but achieved compar-
able intermediate outcomes compared with their
Table 4. Intermediate outcomes in patients with type 2 diabetes according to the general practitioner’s characteristics adjusted
for patient characteristics.
General practitioner’s characteristics
Genderd Specialist statuse Country of birthf Region of graduationg
Variable
Patients
characteristics
Male
n¼ 153
Female
n¼ 124
Specialist
n¼ 187
Non-specialist
n¼ 90
Norway
n¼ 210
Other
n¼ 46
Western Europe
n¼ 222
Other
n¼ 33
HbA1c (%) Alla 7.19 7.20 7.14 7.25 7.19 7.20 7.20 7.19
Maleb 7.24 7.32 7.22 7.34 7.27 7.29 7.28 7.28
Femaleb 7.15 7.09 7.08 7.16 7.12 7.12 7.14 7.11
Norwegiansc 6.83 6.87 6.79 6.91 6.86 6.84 6.86 6.83
South Asiansc 7.42 7.14 7.17 7.40 7.21 7.36 7.37 7.19
Othersc 7.34 7.36 7.34 7.36 7.36 7.34 7.27 7.43
SBP (mmHg) Alla 134.0 133.8 133.0 134.7 134.1 133.6 133.6 134.1
Maleb 134.9 134.6 133.6 135.9 134.9 134.7 134.4 135.1
Femaleb 134.1 133.9 133.5 134.5 134.5 133.5 133.6 134.3
Norwegiansc 139.2 139.2 138.4 140.1 139.6 138.8 138.4 140.1
South Asiansc 129.3 127.0 127.1 129.2 127.5 128.8 130.9 125.4
Othersc 132.5 132.2 131.4 133.3 132.5 132.2 132.3 132.4
DBP (mmHg) Alla 77.3 77.1 77.0 77.4 77.2 77.2 76.6 77.8
Maleb 78.7 78.5 78.0 79.2 78.7 78.5 77.9 79.3
Femaleb 76.3 76.0 76.6 75.7 76.1 76.2 75.6 76.7
Norwegiansc 80.8 80.8 80.5 81.1 80.8 80.8 79.9 81.6
South Asiansc 77.1 75.8 77.2 75.7 79.6 76.0 76.5 76.5
Othersc 78.6 77.7 78.2 78.1 77.9 78.4 77.7 78.6
LDL chol (mmol/L) Alla 2.75 2.72 2.74 2.73 2.74 2.74 2.71 2.76
Maleb 2.69 2.67 2.68 2.68 2.67 2.69 2.63 2.73
Femaleb 2.86 2.82 2.85 2.83 2.86 2.82 2.83 2.85
Norwegiansc 2.92 2.89 2.90 2.90 2.90 2.91 2.87 2.94
South Asiansc 2.92 2.89 2.97 2.84 2.94 2.87 2.87 2.92
Othersc 2.82 2.87 2.86 2.83 2.83 2.85 2.83 2.86
p< 0.05.p< 0.01.p< 0.001.
Linear multilevel regression with practice random effects were used to estimate the adjusted means and differences in mean values. The models were
adjusted for patient age, GP age, and
apatient gender, ethnicity, educational level,
bpatient ethnicity, educational level,
cpatient gender, educational level,
dGP specialist status, country of birth and region of graduation,
eGP gender, country of birth and region of graduation,
fGP gender, specialist status and region of graduation,
gGP gender, specialist status and country of birth.
SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL chol: LDL cholesterol. Others: patients born in other countries.
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counterparts. On the other hand, Berthold and col-
leagues found that female physicians regardless of
speciality were more likely to reach target values of
HbA1c, BP and LDL-cholesterol which are not in agree-
ment with our results [15]. The patients of female GPs
were more often South Asians and less educated prob-
ably indicating challenges with language barriers and
low health literacy.
According to another Norwegian study, GPs born
outside Norway provided care for a different patient
population, often in small and rural practices [26], they
also had broad cultural competency, worked hard for
their patients [27] and their practice pattern differed
little from that of GPs born in Norway regarding out-
of-hours work [28]. These reports are consistent with
our results that GPs born outside Norway provided
comparable intermediate outcomes compared with
their counterparts. Our results may indicate the ability
of these GPs to adapt their clinical practice to provide
good care for their T2DM patients.
Regardless of speciality, physicians graduating
abroad provided similar quality of care compared
with their counterparts in acute myocardial infarc-
tion with respect to secondary prevention medica-
tions and mortality risk in Canada [29] and
mortality in the United States [30]. We found
slightly different findings in that GPs who grad-
uated outside Western Europe performed recom-
mended procedures less often and achieved higher
diastolic blood pressure than GPs who had grad-
uated in Western Europe.
Conclusion and implications
Specialists in General Practice provided better care for
patients with T2DM compared with non-specialists.
Few differences in the quality of T2DM care were
found between GP groups stratified according to their
gender, country of birth and region of graduation.
Interestingly there was considerable potential for
improvement in the screening for microvascular com-
plications such as albuminuria and foot examination in
all GP groups. Better performance here would prob-
ably improve patient outcomes in the long run.
In the future all Norwegian GPs will be required to
undertake specialist training and this will probably
improve diabetes care. Other national strategies to
improve diabetes care in general practice could
include reimbursement to GPs who include a diabetes
nurse in their practice, better collaboration with endo-
crinologists for patients with high risk for complica-
tions and financial incentives to improve GPs
participation in the Norwegian Diabetes Registry.
Future research investigating difference in quality of
care between specialists and non- specialists in general
practice in the management of other chronic condi-
tions would be of interest.
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